INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09969 INNOCARE

Market Closed 04-24 16:08:27

14.700

+0.620

+4.40%

High14.920	Low14.100	Vol9.12M
Open14.410	D1 Closing14.080	Amplitude5.82%
Mkt Cap25.90B	Tradable Cap21.96B	Total Shares1.76B
T/O132.97M	T/O Rate0.61%	Tradable Shares1.49B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"INNOCARE","latestPrice":14.7,"timestamp":1777018107010,"preClose":14.08,"halted":0,"volume":9117042,"delay":0,"changeRate":0.044034090909090856,"floatShares":1494000000,"shares":1762000000,"eps":0.4355473022738313,"marketStatus":"Market Closed","change":0.62,"latestTime":"04-24 16:08:27","open":14.41,"high":14.92,"low":14.1,"amount":132966281,"amplitude":0.058239,"askPrice":14.7,"askSize":29000,"bidPrice":14.68,"bidSize":6000,"shortable":3,"etf":0,"ttmEps":0.4355473022738313,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":7,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":14.08,"openAndCloseTimeList":[[1776994200000,1777003200000],[1777006800000,1777017600000]],"volumeRatio":1.0018707655380605,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"Innocare Pharma Limited","latestPrice":28.47,"timestamp":1777014000000,"preClose":28.38,"halted":0,"volume":13478300,"delay":0,"premium":"-54.95"}},"requestUrl":"/m/hq/s/09969/wiki","defaultTab":"wiki","newsList":[{"id":"1167024959","title":"INNOCARE Calls 16 June AGM to Vote on 2026 Share Incentive Scheme, RSU Grants and Governance Amendments","url":"https://stock-news.laohu8.com/highlight/detail?id=1167024959","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167024959?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:43","pubTimestamp":1777041829,"startTime":"0","endTime":"0","summary":"INNOCARE will hold its annual general meeting on 16 June 2026 in Beijing. Shareholders will review the 2025 Annual Report, which recorded operating revenue of RMB 2.37 billion and the first full-year...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199481869","title":"Innocare Awards 15.39 Million Restricted Share Units","url":"https://stock-news.laohu8.com/highlight/detail?id=1199481869","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199481869?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:27","pubTimestamp":1777037253,"startTime":"0","endTime":"0","summary":"Innocare (09969) announced that on April 24, 2026, the company granted 15.3892 million restricted share units under the 2023 Equity Incentive Plan to three grantees. These units represent...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688428","BK1574","09969","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198970011","title":"InnoCare issues 15.39 million RSUs; executive portion subject to AGM vote","url":"https://stock-news.laohu8.com/highlight/detail?id=1198970011","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198970011?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:24","pubTimestamp":1777037060,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited announced that on 24 April 2026 the board approved a grant of 15.39 million restricted share units (RSUs), equal to about 0.87 % of issued shares (excluding treasury stock),...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176300554","title":"Stock Track | INNOCARE Soars 5.11% Intraday on Stellar Q1 2026 Results with 489% Net Profit Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1176300554","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176300554?lang=en_us&edition=fundamental","pubTime":"2026-04-24 10:35","pubTimestamp":1776998137,"startTime":"0","endTime":"0","summary":"INNOCARE's stock price surged 5.11% during intraday trading on Friday, reflecting strong investor sentiment following the release of the company's latest financial performance.The significant price...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160384501","title":"Carbon Peak and Carbon Neutrality Evaluation Measures Released; Innocare Q1 Net Profit Surges 488.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160384501","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160384501?lang=en_us&edition=fundamental","pubTime":"2026-04-24 07:27","pubTimestamp":1776986822,"startTime":"0","endTime":"0","summary":"China's General Office of the Communist Party of China Central Committee and the General Office of the State Council have jointly issued the \"Comprehensive Evaluation and Assessment Measures for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1175","159790","09969","BK1513","02600","BK0239","BK1161","BK1568","BK1574","BK4585","LU1808992512.USD","VXUS","688428","BK1170","BK4588","BK1592","00148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183810232","title":"创新药企InnoCare 2025年度业绩显著提升，首度实现盈利并拓展多元业务布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1183810232","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183810232?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:07","pubTimestamp":1776942478,"startTime":"0","endTime":"0","summary":"2025年，InnoCare业绩呈现大幅增长，全年营业收入约23.749亿元（人民币，下同），较2024年的10.094亿元同比上升135.3%，并实现上市以来的首次年度盈利，净利润约6.442亿元，相比上一年度亏损4.529亿元出现明显反转。管理层表示，这一表现主要来自于在研及在售产品的商业化推进、多项全球业务合作的收入确认，以及布局血液肿瘤、自身免疫疾病与实体瘤等多个治疗领域的综合带动。...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"创新药企InnoCare 2025年度业绩显著提升，首度实现盈利并拓展多元业务布局","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169828632","title":"INNOCARE 2025 ESG Report: First-Time Profit, RMB 951.60 Million R&D Outlay and 60.75 % Carbon-Intensity Cut","url":"https://stock-news.laohu8.com/highlight/detail?id=1169828632","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169828632?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:06","pubTimestamp":1776942388,"startTime":"0","endTime":"0","summary":"INNOCARE released its 2025 Environmental, Social and Governance (ESG) Report, outlining the group’s first year of profitability, significant environmental gains and continued investment in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157412736","title":"InnoCare Pharma Q1 2026: Net Profit Jumps 4.9-Fold on 45% Drug-Sales Surge, Cash Pile Tops 7.92 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1157412736","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157412736?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:05","pubTimestamp":1776942327,"startTime":"0","endTime":"0","summary":"InnoCare Pharma released its unaudited first-quarter 2026 results, highlighting a sharp turnaround in profitability on the back of strong product demand and milestone income. Revenue and Earnings   •...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180322339","title":"Xie Zhiyu's Q1 Portfolio Revealed: Increased Bets on Chemical and Energy Storage Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1180322339","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180322339?lang=en_us&edition=fundamental","pubTime":"2026-04-21 21:53","pubTimestamp":1776779624,"startTime":"0","endTime":"0","summary":"Prominent fund manager Xie Zhiyu has disclosed his first-quarter portfolio holdings. Taking the Xingquan Herun Mixed Fund as an example, Xie executed a clear sector rotation strategy during the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ86797644.SGD","IE0008368304.USD","LU0188438112.USD","LU1880383366.USD","SGXZ81163826.USD","LU0819123356.HKD","LU0327786744.USD","LU0228659784.USD","LU1961090484.USD","LU0082770016.SGD","LU0117841782.USD","LU0642271901.SGD","LU1880383440.USD","LU1323998911.USD","LU1548497426.USD","HK0000320264.USD","BK0070","LU0345776255.USD","LU2294711713.HKD","LU1580142542.USD","LU0307460666.USD","LU2357125470.USD","SG9999001846.SGD","LU0229945570.USD","LU0052750758.USD","LU2449936058.SGD","LU0251143458.SGD","LU0192582467.USD","LU0502904849.HKD","LU0128522744.USD","LU0572944931.SGD","LU0516423174.USD","LU0605514214.HKD","LU1152091168.USD","LU1960683339.HKD","LU0531971595.HKD","BK1521","LU2238339852.HKD","LU0067412154.USD","LU1808992512.USD","LU2153592121.USD","LU0577902611.USD","LU1655091616.SGD","LU0572940350.SGD","IE00B8L5B284.USD","LU2298322129.HKD","LU1282649810.SGD","LU0700851271.USD","LU0608807433.USD","01801","LU0509642566.USD","LU2580892862.HKD","LU0634319403.HKD","LU0651947912.USD","LU0140636845.USD","LU0505663152.USD","LU1152091754.HKD","LU0648948544.HKD","LU0762541174.USD","IE00BZ199S13.USD","LU2328871848.SGD","BK0073","LU1224709979.USD","LU0043850808.USD","LU2257852520.SGD","LU1366334651.USD","BK1116","LU1188198961.HKD","LU1880398471.USD","LU0577902298.EUR","LU2348773727.SGD","LU0708995153.HKD","LU0516422440.USD","LU2087589342.USD","LU0501845795.SGD","LU0821914370.USD","LU0898667661.SGD","LU2348774022.SGD","SG9999006514.SGD","LU1146622755.USD","BK0231","LU1303224171.USD","LU1997245177.USD","LU0048597586.USD","LU1504937902.USD","LU0130518102.USD","LU0456827905.SGD","BK1097","LU1861219969.SGD","LU1807302812.USD","LU1008478684.HKD","LU0287142896.SGD","300750","LU0082770016.USD","LU2580892789.USD","BK1517","LU0348805143.USD","LU0348783662.USD","LU0210527791.USD","LU2097828631.EUR","IE0032431581.USD","BK0196","LU0543330566.HKD","LU0823397285.USD","LU0348784397.USD","BK1575","LU0651946864.USD","LU1102505762.USD","LU1196710864.SGD","LU0630378692.HKD","LU0359201885.HKD","LU0823040885.USD","BK0167","LU0823426308.USD","LU0106252389.USD","LU0106259558.USD","SG9999001093.SGD","LU0320764243.SGD","LU0244354667.USD","02423","LU0149534421.HKD","600426","LU1810669033.SGD","LU0417516571.SGD","LU1282649067.USD","LU0329678170.USD","IE00BPRC5H50.USD","LU0348825331.USD","LU0384037296.USD","LU2097829019.USD","LU0370786039.SGD","600160","LU0107464264.USD","IE00BMPRXN33.USD","IE00BZ08YS42.EUR","HK0000151867.HKD","LU0211977185.USD","LU2125910500.SGD","IE0034224299.USD","LU2125910849.SGD","LU0029874905.USD","LU0164880469.USD","LU0823414551.USD","LU1251922891.USD","IE00BZ08YT58.USD","LU0762540952.USD","LU2424517915.HKD","LU1051768304.USD","LU0405327494.USD","LU0791590937.USD","BK1142","LU1568876335.HKD","LU1242518931.SGD","LU0329678337.USD","LU0791591158.USD","IE00B12V2V27.USD","BK0044","LU0072913022.USD","LU1044876610.USD","LU0561508036.HKD","LU2242644610.SGD","LU0856984785.SGD","SG9999014674.SGD","LU2399975544.HKD","LU0441854154.USD","SG9999002828.SGD","LU0049853897.USD","LU0543330483.HKD","LU0011963245.USD","BK1584","LU0890818403.SGD","LU2023250504.SGD","LU2039709279.SGD","LU2360108059.USD","SGXZ62798434.SGD","LU1048596156.SGD","LU1688375341.USD","BK0064","LU1224444064.USD","LU0672654166.SGD","LU0784639295.USD","LU1044875133.USD","LU2152927971.USD","LU0261950983.USD","LU2275660780.HKD","LU1956131251.USD","HK0000306685.HKD","LU2357305700.SGD","LU0588545490.SGD","BK0028","BK0229","LU0823041008.USD","LU0048575426.USD","LU0588545904.SGD","LU1064131003.USD","LU1102505929.USD","HK0000181138.USD","LU0315178854.USD","LU0149721374.USD","SG9999000327.SGD","LU2097828805.USD","BK0072","LU0048388663.USD","SG9999003461.SGD","LU0359201612.USD","LU0762542818.HKD","000683","LU0620787316.HKD","LU2495084118.USD","09969","LU1211504680.USD","BK1502","LU0880133367.SGD","BK0224","HK0000306701.USD","LU1720051017.SGD","LU0054237671.USD","LU0589944569.HKD","BK0061","SG9999001226.SGD","LU0315179316.USD","IE00B3M56506.USD","BK0201","LU1770034418.SGD","EVS.SI","LU0831103253.SGD","LU0708995583.HKD","LU0724618433.USD","BK1588","BK1608","LU1439103000.SGD","LU0261950470.USD","LU0061477393.USD","LU0348735423.USD","LU0823038988.USD","IE00B0JY6N72.USD","BK0251","HK0000181112.HKD","LU0541502299.USD","LU0254981946.USD","LU1979443071.USD","03750","LU2294711473.HKD","LU2476274720.SGD","HBBD.SI","LU0164872284.USD","09988","LU2041044095.USD","BK0152","ALBmain","LU0588545730.USD","LU0588546209.SGD","LU0862451753.SGD","LU0143863198.USD","LU0607220059.USD","LU2488822045.USD","LU1794554557.SGD","SG9999004220.SGD","LU2394011477.USD","LU1201861165.SGD","LU0477156797.USD","LU1328615791.USD","BK1610","BABA","LU2506952253.HKD","LU1969619763.USD","LU0196878994.USD","LU0577902371.SGD","IE00B29SXG58.USD","688099","LU0096374516.USD","LU0251144936.SGD","LU1282651048.USD","LU1880398554.USD","LU0431992006.USD","HK0000320223.HKD","SG9999001903.USD","LU2298321311.HKD","LU2097828714.EUR","LU3063872942.SGD","LU2506952410.USD","IE0003895053.USD","LU0541501648.USD","LU0823413587.USD","SG9999002463.SGD","LU1769817179.HKD","LU1997245094.SGD","BK0188","LU0197773673.USD","LU0611395673.USD","LU0449515922.USD","LU1720051108.HKD","LU0396098781.USD","IE00B0169N27.USD","LU0302445910.USD","LU0499858602.USD","LU1316542783.SGD","IE0003795394.USD","LU2153591404.USD","BK0077","BK1249","BK1615","LU1861214812.USD","LU1328277881.USD","LU2148510915.USD","LU0214875030.USD","LU0823414478.USD","LU0048580855.USD","002008","LU0463099449.HKD","LU2106854487.HKD","LU1769817096.USD","688008","LU0531970944.HKD","LU1515016050.SGD","LU0488056044.USD","LU0173614495.USD","SGXZ49509284.SGD","IE00B5MMRT66.SGD","LU2249611893.SGD","LU0819121731.USD","LU0516423091.SGD","LU2097828557.USD","LU2476274308.USD","LU0449509016.USD","LU0540923850.HKD","SG9999001689.USD","LU0594300179.USD","LU0640798160.USD","IE00B543WZ88.USD","LU0648000940.SGD","LU2506952337.HKD","LU0828237940.HKD","LU0320764755.SGD","LU0675040207.SGD","LU0047713382.USD","LU0348783233.USD","LU0886674414.USD","LU0106959298.USD","IE00BYTNYN87.SGD","LU0164865239.USD","LU1868837565.USD","LU0130103400.USD","LU0469268626.HKD","LU1255011170.USD","BK1618","SG9999000459.SGD","LU0235996351.USD","LU0320764599.SGD","LU0577902538.SGD","LU0072462343.USD","LU1939255532.USD","LU1568876251.USD","BK0214","LU0051755006.USD","LU0862451837.USD","LU2097828474.EUR","LU0264606111.USD","LU0210526637.USD","HK0000286598.CNH","LU0197773160.USD","LU1770036033.HKD","LU0823437842.USD","BK1586","LU0314109678.HKD","LU1242518857.USD","SG9999011746.SGD","LU0169518387.USD","LU0127658192.USD","LU1048588211.SGD","LU0608807946.USD","LU0455707207.USD","LU0868486357.SGD","LU1366334578.USD","SGXZ90724238.SGD","HK0000107257.USD","IE00B8HQ1Z84.USD","LU0417516738.SGD","LU0823397103.USD","LU1282649141.HKD","LU1064130708.USD","BK0015","LU0117844026.USD","LU1934453819.USD","LU0594300419.USD","LU0831093199.SGD","LU0650527681.SGD","LU1820825898.SGD","LU0979878070.USD","605117","LU0054450605.USD","LU0417516902.SGD","LU0164939612.USD","LU1978683503.SGD","IE00BZ08YR35.GBP","LU1917777945.USD","LU1868838027.USD","LU0345775950.USD","BK1589","LU1481107354.HKD","LU1721428347.USD","LU2213484517.USD","LU0269904917.USD","LU0029875118.USD","LU0326948709.USD","LU0871576103.HKD","300308","BK0066","LU0228367735.SGD","LU1719994722.HKD","LU0084288322.USD","LU0572939691.SGD","LU1039395188.USD","LU0823039010.USD","LU2778985437.USD","BK1583","LU0823413660.USD","LU0823426480.USD","BK1161","LU0499858438.USD","LU0865486749.SGD","LU1282651121.HKD","LU0143863784.USD","LU0312595415.SGD","LU0128522157.USD","LU2506951792.HKD","LU0181495838.USD","LU0828237510.HKD","IE00BYQNZ168.SGD","LU1813983027.USD","LU1974910355.USD","LU0348788117.USD","LU0132412106.USD","LU2092937221.SGD","LU0405327148.USD","LU1051769294.HKD","LU2289578879.USD","LU0593848301.USD","LU0261947096.USD","688120","LU0630378429.USD","LU2298064838.USD","LU1023057109.AUD","LU1993786604.SGD","LU0259732245.USD","SG9999002562.SGD","LU2293587155.HKD","BK0187","LU1044874839.SGD","89988","LU0737861772.HKD","HK0000165453.HKD","LU0163747925.USD","LU0516422952.EUR","LU0293314216.USD","LU1048484197.HKD","LU0231483743.USD","LU1981816686.USD","LU1720050803.USD","SG9999001051.SGD","LU0737861699.HKD","LU0516422366.SGD","LU0828238088.HKD","LU1781817850.SGD","BK1501","LU0326950275.SGD","LU0348827113.USD","LU0456846285.SGD","LU1115378108.SGD","BK1591","LU0039217434.USD","LU0359202008.SGD","LU0328353924.USD","LU0124384867.USD","IE00BMPRXR70.SGD","LU1642822792.SGD","SG9999006597.SGD","LU2360107325.USD","LU2045819591.USD","LU1831875114.USD","LU0456842615.SGD","IE00BD6J9T35.USD","LU1997244956.HKD","BK1574","LU0165289439.USD","LU2477742899.HKD","IE0003851619.USD","LU0577902454.USD","LU0873338254.USD","LU1655091459.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134446676","title":"InnoCare Pharma Sets 23 April Board Meeting to Approve Q1 2026 Unaudited Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1134446676","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134446676?lang=en_us&edition=fundamental","pubTime":"2026-04-10 17:22","pubTimestamp":1775812956,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited announced that its Board of Directors will convene on 23 April 2026 to review and approve the unaudited consolidated results for the three-month period ended 31 March 2026....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625299010","title":"Assessing InnoCare Pharma (SEHK:9969) Valuation After Its 2025 Profit Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=2625299010","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625299010?lang=en_us&edition=fundamental","pubTime":"2026-04-08 11:24","pubTimestamp":1775618675,"startTime":"0","endTime":"0","summary":"Earnings shift draws fresh attention to InnoCare Pharma\nInnoCare Pharma (SEHK:9969) has drawn fresh attention after reporting full year 2025 sales of CN¥2,374.91 million and net income of CN¥642.47 million, compared with a net loss a year earlier.\nSee our latest analysis for InnoCare Pharma.\nThe earnings swing has coincided with strong price momentum, with a 31.19% 1 month share price return and a 24.16% year to date share price return at HK$15.52. The 1 year total shareholder return of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/assessing-innocare-pharma-sehk9969-valuation-after-its-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/assessing-innocare-pharma-sehk9969-valuation-after-its-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1574","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176977130","title":"Innocare Pharma Reports Annual Revenue of 23.75 Billion Yuan with 642 Million Yuan Net Profit; King Bridge Exits Entire Stake Potentially Realizing Over 2 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1176977130","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176977130?lang=en_us&edition=fundamental","pubTime":"2026-04-07 18:02","pubTimestamp":1775556123,"startTime":"0","endTime":"0","summary":"Innocare Pharma Limited (Stock Code: 688428) has released its financial results for the year ended December 31, 2025. The report indicates the company achieved annual revenue of 23.75 billion yuan, a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1574","09969","BK1161","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164546936","title":"Goldman Sachs Slightly Raises Innocare Target to HK$19.93 on Strong Q4 Sales of Orelabrutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=1164546936","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164546936?lang=en_us&edition=fundamental","pubTime":"2026-03-30 15:40","pubTimestamp":1774856423,"startTime":"0","endTime":"0","summary":"Goldman Sachs has issued a research report noting that INNOCARE (09969) reported sales of Orelabrutinib reaching RMB 390 million in the fourth quarter of last year, a 27% year-on-year increase....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688428","BK1161","BK1574","09969","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623635363","title":"A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2623635363","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623635363?lang=en_us&edition=fundamental","pubTime":"2026-03-30 02:06","pubTimestamp":1774807596,"startTime":"0","endTime":"0","summary":"Recent share performance and business snapshot\nInnoCare Pharma (SEHK:9969) has drawn investor attention after a 5.7% one day gain, adding to a one month return of 12.8% and a past 3 months return recorded as 0%.\nThe Hong Kong listed biopharmaceutical group focuses on cancer and autoimmune disease treatments in China, with revenue of CN¥2,374.906 million and net income of CN¥642.467 million reported in its latest figures.\nSee our latest analysis for InnoCare Pharma.\nAt the current share price...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09969","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622049558","title":"The InnoCare Pharma Limited (HKG:9969) Yearly Results Are Out And Analysts Have Published New Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2622049558","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622049558?lang=en_us&edition=fundamental","pubTime":"2026-03-28 07:53","pubTimestamp":1774655610,"startTime":"0","endTime":"0","summary":"Investors in InnoCare Pharma Limited ( HKG:9969 ) had a good week, as its shares rose 7.5% to close at HK$13.11...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/the-innocare-pharma-limited-hkg9969-yearly-results-are-out-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/the-innocare-pharma-limited-hkg9969-yearly-results-are-out-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK1161","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157407752","title":"Stock Track | InnoCare Pharma Soars 5.08% Intraday on Strong Q4 Profit Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1157407752","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157407752?lang=en_us&edition=fundamental","pubTime":"2026-03-27 10:09","pubTimestamp":1774577352,"startTime":"0","endTime":"0","summary":"InnoCare Pharma's stock soared 5.08% during intraday trading on Friday, reflecting positive market sentiment following the release of its quarterly financial results.The company reported a sharp...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622486033","title":"InnoCare Pharma (SEHK:9969) Q4 Profit Surge Challenges Bearish Earnings Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2622486033","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622486033?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:15","pubTimestamp":1774534502,"startTime":"0","endTime":"0","summary":"Intro\nInnoCare Pharma (SEHK:9969) just closed FY 2025 with fourth quarter revenue of C¥1.3b and net income of C¥706.9m, a sharp step up from the smaller quarterly figures that characterised most of the year. The company has seen quarterly revenue move from C¥311.7m in Q4 2024 to C¥381.3m in Q1 2025, C¥350.2m in Q2, C¥383.9m in Q3 and finally C¥1.3b in Q4, while basic EPS across the year swung between a gain of C¥0.01 in Q1 and losses of C¥0.0396 and C¥0.0188 in Q2 and Q3. This sets up a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-q4-profit-surge-challenges-bearish","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-q4-profit-surge-challenges-bearish","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09969","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127956704","title":"UBS Trims Innocare Pharma Target to HK$19.8, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1127956704","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127956704?lang=en_us&edition=fundamental","pubTime":"2026-03-26 16:18","pubTimestamp":1774513124,"startTime":"0","endTime":"0","summary":"UBS has revised its forecasts for Innocare Pharma (09969), lowering sales projections for 2026 and 2027 while increasing expense estimates. This adjustment reduces the earnings per share forecast for...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688428","BK1161","BK1574","09969","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622368079","title":"Press Release: InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2622368079","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622368079?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:04","pubTimestamp":1774443840,"startTime":"0","endTime":"0","summary":"BEIJING, March 25, 2026  -- InnoCare Pharma , a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual results for 2025 as of December 13, 2025.2025 marked InnoCare's 10th anniversary and a milestone year of transformative growth and strategic execution. The Company achieved its first full year profitability, secured two new drug application  approvals, enhanced market penetration of its core products, accelerated globalization, and made breakthroughs across multiple pipelines. With numerous \"China First\" achievements, InnoCare continues to accelerate its 2.0 development strategy, demonstrating its strong ability to translate scientific innovations into sustainable long-term growth.-- Revenue grew 135.3% year-on-year to RMB 2,375 million1 in 2025, mainly. driven by robust commercial growth and two strategic business development. -- Profit reached RMB 644 million, achieving profitability for the first. time, mainly due to significant com","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLS","LU0203345920.USD","LU1235294995.USD","LU1066051225.USD","IE00B42XCP33.USD","09969","LU1244550577.SGD","LU1894683264.USD","LU2506952170.USD","IE000M9KFDE8.USD","LU1032955483.USD","SG9999001424.SGD","BK4579","LU1883839398.USD","LU1066051498.USD","LU1929549753.HKD","LU1221951046.USD","SG9999015978.USD","LU0823417653.USD","LU1585245621.USD","BK4533","IE00BVYPNV92.GBP","LU0234570918.USD","SG9999015986.USD","LU2286300806.USD","LU1571399168.USD","BK4020","CSCS","LU0792757196.USD","LU2102340556.USD","LU2237443978.SGD","BK4585","LU2237443895.HKD","LU1880398471.USD","LU1059921491.USD","IE00BGHQF631.EUR","ORR","IE00BVYPNW00.USD","LU1894683348.USD","CSCL","SG9999015945.SGD","BK4525","LU2237443465.HKD","LU0234572021.USD","LU1599440770.SGD","LU1674673428.USD","CSCO","IE00BSNM7G36.USD","BK4588","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622076953","title":"InnoCare Pharma Turns to 2025 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2622076953","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622076953?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:52","pubTimestamp":1774443128,"startTime":"0","endTime":"0","summary":"InnoCare Pharma  recorded an attributable profit of 642.5 million yuan in the year 2025, compared with an attributable loss of 440.6 million yuan a year prior, according to a Wednesday Hong Kong bourse filing.Earnings per share stood at 0.38 yuan for the period, compared with a loss per share of 0.26 yuan in the previous fiscal year.The pharmaceutical company's revenue surged 135% to 2.37 billion yuan from 1.01 billion yuan previously, mainly due to strong drug sales growth and licensing revenue from collaborations with Zenas Biopharma and Prolium.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","09969","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://cn.innocarepharma.com","stockEarnings":[{"period":"1week","weight":-0.0649},{"period":"1month","weight":0.1903},{"period":"3month","weight":0.2447},{"period":"6month","weight":0.0621},{"period":"1year","weight":0.3973},{"period":"ytd","weight":0.1951}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0.0253},{"period":"3month","weight":-0.0288},{"period":"6month","weight":-0.007},{"period":"1year","weight":0.1857},{"period":"ytd","weight":0.0136}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The Company's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The Company is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The Company conducts its businesses in domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.103999},{"month":2,"riseRate":0.666667,"avgChangeRate":0.128923},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.010195},{"month":4,"riseRate":0.714286,"avgChangeRate":0.11163},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.042592},{"month":6,"riseRate":0.833333,"avgChangeRate":0.12939},{"month":7,"riseRate":0.5,"avgChangeRate":0.039258},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.082108},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.024907},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.033299},{"month":11,"riseRate":0.833333,"avgChangeRate":0.100833},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012645}],"exchange":"SEHK","name":"INNOCARE","nameEN":"INNOCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INNOCARE,09969,INNOCARE股票,INNOCARE股票老虎,INNOCARE股票老虎国际,INNOCARE行情,INNOCARE股票行情,INNOCARE股价,INNOCARE股市,INNOCARE股票价格,INNOCARE股票交易,INNOCARE股票购买,INNOCARE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}